Clinical trial

Efficacy, Safety and Pharmacokinetics of DTG With RIF

NCT03731559

Drugs and interventions used in this trial

2 registered

These interventions are listed by ClinicalTrials.gov. An RxNorm link indicates a mapped medicine record; the registry name alone is not proof of a specific branded formulation.

Search this trial's interventions

DRUG · Unmapped registry intervention DTG 50 mg OD with food Find medicine records · Find other trials using this name

DRUG · Unmapped registry intervention DTG 50 mg BID Find medicine records · Find other trials using this name

Study at a glance

Registry-backed

Efficacy, Safety and Pharmacokinetics of DTG With RIF

Design: INTERVENTIONAL · Status: COMPLETED · Phase: PHASE2

Read study objectives, eligibility and outcome measures at ClinicalTrials.gov

StatusCOMPLETED

Study typeINTERVENTIONAL

Start date2019-06-25

PhasePHASE2

Conditions

HIV/TB Coinfectionunresolved

Interventions

DTG 50 mg OD with foodDRUG

DTG 50 mg BIDDRUG

Sponsors & collaborators

The HIV Netherlands Australia Thailand Research Collaborationlead sponsor

Chulalongkorn Universitycollaborator

Bamrasnaradura Infectious Diseases Institutecollaborator

Bhumibol Adulyadej Hospitalcollaborator

Infectious Disease Taksin Hospitalcollaborator

Klang Hospitalcollaborator

Infectious Disease Chiangrai Prachanukroh Hospitalcollaborator

Infectious Disease Chonburi Hospitalcollaborator

Infectious Disease Buddhachinaraj Phitsanulok Hospitalcollaborator

Radboud University Medical Centercollaborator

Ministry of Health, Thailandcollaborator

Mapped research locations

BangkokThailand2

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT03731559 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.